Faculty

Dr. Glaspy is a Professor of Medicine in the Division of Hematology-Oncology at the UCLA School of Medicine. He is the Director of the Cancer Center’s Clinical Research Unit, and actively involved in translational and clinical research, with research interests including: breast cancer, melanoma, and the management of hematopoiesis during chemotherapy. He currently holds the Estelle, Marjorie and Abe Sanders Endowed Chair in Cancer Research

Dr. Lyman is currently Professor of Medicine and Oncology at the University of Rochester School of Medicine and Dentistry and Director of Health Services and Outcomes Research at the James P Wilmot Cancer Center at the University of Rochester Medical Center in Rochester, New York. Dr. Lyman received his undergraduate and medical degree from the State University of New York at Buffalo. He then pursued a residency in medicine at the University of North Carolina in Chapel Hill and a fellowship in Medical Oncology and Hematology at the Roswell Park Memorial Institute. Dr. Lyman did additional postdoctoral training in biostatistics at the Harvard School of Public Health and the Dana Farber Cancer Institute in Boston. He was previously on the faculty of the H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida where he was Professor of Medicine and Chief of the Medical Service as well as Professor of Epidemiology and Biostatistics at the School of Public Health.

From 1997-1998 he was Visiting Professor in the Biostatistics Unit of the London School of Hygiene and Tropical Medicine. From 2000-2002 he was the Thomas Ordway Professor of Medicine and Director of the Division of Hematology/ Oncology in the Department of Medicine at the Albany Medical College and Director of the Cancer Center at the Albany Medical Center. He also served as Professor of Biometry and Statistics at SUNY-Albany School of Public Health.

Professor Lyman is board certified in internal medicine, medical oncology and hematology. He is a fellow of the Royal College of Physicians (Edin), the American College of Physicians, the American College of Clinical Pharmacology and the American College of Preventive Medicine. Dr. Lyman’s research interests include the design and analysis of clinical trials, evidence based medicine and clinical reasoning, health technology assessment and pharmacoeconomic analysis. He is also involved in the development of mathematical and statistical prognostic and predictive models to enhance the targeted and cost-effective application of new molecular diagnostic and therapeutic modalities.

Dr. Leon E. Cosler received his B.S. in Pharmacy from Albany College of Pharmacy in 1982. He received his M.S. in Pharmacy Administration from West Virginia University School of Pharmacy in 1984 and his doctorate in Administrative and Engineering Systems (Health Systems Administration) from Union College in 1992. Prior to 2001, he served as the Director of Research for the New York State Medicaid program. Dr. Cosler then joined the faculty of Albany College of Pharmacy in March, 2001 as Assistant Professor of Pharmacoeconomics. His area of expertise includes economic decision analysis and the analysis of large patient claims databases. His interests include cost-effectiveness analysis, decision modeling, and health outcomes research. He is the founding Director of the Research Institute for Health Outcomes (RIHO) at the Albany College of Pharmacy.

Christopher R. Friese, RN, PhD, AOCN^® is currently research fellow at the Center for Outcomes and Policy Research and Associate Clinical Scientist at the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at the Dana-Farber Cancer Institute in Boston, Massachusetts. He is also a fellow in Cancer Prevention and Control at the Harvard School of Public Health. Dr. Friese conducts research on outcomes of care for patients with cancer, and organizational factors associated with quality of care. He is principal investigator of the Oncology Nursing Society Foundation–funded study Neutropenia Outcomes: Nurse Staffing and Practice Environment Effects. He has received research funding from the National Institute of Nursing Research, the American Cancer Society, and the Oncology Nursing Society. He completed his bachelor, masters, and doctoral degrees at the University of Pennsylvania. He serves on the advisory board of the doctoral program in nursing, cancer, and health disparities at the University of Massachusetts-Boston.

Dr. Friese received a Young Investigator award from the Multinational Association of Supportive Care in Cancer in 2005 and a Merit Award from the American Society of Clinical Oncology in 2006. He lectures nationally and internationally on the topic of supportive care in cancer. His research findings have been published in Nursing Research, Oncology Nursing Forum, and the Clinical Journal of Oncology Nursing. He is research consultant and co-author of the Oncology Nursing Society’s Putting Evidence Into Practice: Evidence Based Summary for the Prevention of Infection. He has practiced in some of the nation’s leading cancer centers, including the Kimmel Cancer Center at Johns Hopkins, the Abramson Cancer Center at the University of Pennsylvania, and the Fox Chase Cancer Center. Dr. Friese remains an active nurse clinician in the hematologic malignancies/bone marrow transplant setting.

Medical Writer

Shanna J. McClennen, PhD

Disclosure Policy

It is the policy of ArcMesa Educators to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All faculty/authors are expected to disclose any relevant financial relationships they may have with commercial interests in relation to this activity. These relationships, along with the educational content of this program, have been reviewed and any potential conflicts of interest have been resolved to the satisfaction of ArcMesa Educators.

Staff Disclosure Declarations

The employees of ArcMesa Educators have no financial relationships to disclose.

Faculty Disclosure Declarations

Leon E. Cosler, RPh, PhD – Unrestricted Research Support and Honorarium – Amgen

John Glaspy, MD, MPH – Research Support Recepient – Amgen, Ortho Biotech

Gary H. Lyman, MD, MPH, FRCP (Edin) – Research Support Recepient and Speakers’ Bureau – Amgen

Christopher R. Friese, RN, PhD, AOCN^® – Consultant, Speakers’ Bureau/Honorarium recipient, Stock Shareholder – Amgen; Stock Shareholder – Novartis

Don Tessier (Medical Writer) – Nothing to disclose

Shanna J. McClennen, PhD (Medical Writer) – Nothing to disclose

Printer settings may vary. Please use landscape layout option.

Copyright © 2006 ArcMesa Educators / CMEdiscovery.com. All rights reserved.